ZIM Laboratories Limited share price
NSE: ZIMLAB · ISIN INE518E01015
Key numbers
- Market cap
- ₹ 743 Cr
- Current price
- ₹ 138.48
- 52-week high / low
- ₹ 144 / 59
- Stock P/E
- 171.0
- Book value
- ₹ 55.4
- Dividend yield
- 0.00%
- ROCE
- 5.1%
- ROE
- 2.1%
- Debt to equity
- 0.43
- Sales growth (3 yrs)
- -2.5%
- Profit growth (3 yrs)
- -37.9%
- 1-year return
- 84.1%
About ZIM Laboratories Limited
ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. It provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, directly compressible granules, tablets, capsules, dry syrup, and oral thin films. The company offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and vitamins and supplements. The company was founded in 1984 and is based in Nagpur, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 72 | 89 | 109 | 105 | 94 |
| Operating profit | 4 | 6 | 13 | 7 | 2 |
| Net profit | -2 | -0 | 4 | 4 | -4 |
| EPS (₹) | -0.38 | -0.09 | 0.90 | 0.76 | -0.75 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.